RedHotStocks

NanoViricide Upside Targets $nnvc

Pembelian
AMEX:NNVC   NanoViricides, Inc.
NanoViricides (NYSEMKT:NNVC) jumps 36% after hours in reaction to its announcement related to its development plans for a drug to treat COVID-19 infection.
Management intends to conduct initial testing of its drug candidates in its own virology laboratory using low-threat coronavirus strains that have been normally circulating in the human population. If successful, it has the ability to make "kilogram quantities" in just a few weeks which, it says, would be sufficient to treat several hundred to a few thousand patients.
Source seeking alpha

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.